The blockbuster weight loss drugs that are taking the pharmaceutical market by storm may offer some additional benefits, ...

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss ...

In a groundbreaking new study, Ozempic was found to be so effective at treating arthritis that people no longer needed ...

A new study reported in the New England Journal of Medicine found that GLP-1 drugs such as Ozempic and Wegovy which have ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, ...

Newer medications to treat diabetes and obesity are saving lives, but those who need the injectable drugs the most, were the ...

On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from part 1 of the ongoing ESSENCE Phase 3 trial, a 240-week ...

( NewsNation) — An active ingredient in some weight-loss drugs could help people suffering from osteoarthritis knee pain, a ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

Novo Nordisk said on Friday its weight-loss drug Wegovy met the main goal of a late-stage trial by showing improvement in liver fibrosis with no worsening of steatohepatitis.

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

That's how the opportunity to test a form of the "miracle" weight loss drug GLP-1 (also known also as semaglutide, or by its ...